Page 2 THE REVERE ADVOCATE – FRIDAY, JULY 31, 2026 MASS.HOUSE | FROM Page 1 House, along with our partners in the Senate, for recognizing the need for these important protections.” “Today the Legislature took a bold step forward, ensuring that residents in Massachusetts will be safer when they enter a hospital, now knowing that the medical implements and equipment utilized are free of unnecessary containments,” said Senator Michael J. Rodrigues, Chair of the Senate Committee on Ways and Means. “This legislation will phase out the manufacturing and selling of DEHP, a known environmentally harmful additive to IV bags and tubing. We need to do all we can to make our health care environment the safest possible for all patients in Massachusetts. I would like to thank Senator Lovely and Representative O’Day for their staunch advocacy in the passage of this legislation.” “Every patient deserves the peace of mind that the medical devices used in their care are as safe as possible. By eliminating unnecessary ex“WE’RE STILL HERE!” Since 1947 MALDEN AUTO BODY Book online: Maldenauto.com 49 Robin St., Everett, MA 617-389-3030 * Maldenab@yahoo.com Over 79 years of exceptional service! Massone Family Owned & Operated posure to DEHP in IV bags and tubing, this legislation takes a meaningful step to reduce preventable health risks while advancing safer standards of care across the Commonwealth. I’m proud to support this bipartisan eff ort to strengthen patient safety and protect public health,” said Representative Jessica Giannino (D-Revere). “Massachusetts is always a national leader in medical treatment and care. This legislation makes a bold statement that we can have medical treatment and care without endangering our health due to the presence of toxic chemicals. The need for this legislation was obvious, and I am happy to have worked with my colleagues to address this issue,” said Representative Jeffrey Rosario Turco (D-Winthrop). The legislation—S.3106, An Act relative to toxic-free medical devices—would prohibit the manufacture or sale of IV containers and tubing made with intentionally added DEHP. DEHP—Di (2-ethylhexyl) phthalate—has been linked to breast, liver, lung, and testicular cancer, according to Breast Cancer Prevention Partners. “We are once again elevating the standard of care in the Commonwealth and we should all be proud of that. When implemented, this will improve the health of patients by decreasing exposure to toxins and known carcinogens,” said Senator William J. Driscoll Jr. (D-Milton), Senate Chair of the Joint Committee on Public Health. “We have a duty to keep patients and healthcare providers safe. As the Senate Chair of Public Health and a family member with loved ones receiving the types of care that this legislation applies to, I am grateful to all involved who took action to bring this to the legislature’s attention and ultimately over the fi nish line into law. This result represents meaningful collaboration between legislators, staff , healthcare professionals, industry leaders, patients, and advocates.” “We know that DEHP poses serious health risks, disrupting hormone systems and increasing cancer risk,” said Representative Marjorie C. Decker (D-Cambridge), House Chair of the Joint Committee on Public Health. “This legislation is a vital step in protecting public health by banning the sale and manufacture of IV bags and tubes that contain this toxic chemical. By eliminating DEHP, we commit to safer alternatives, prioritizing the health and well-being of our communities.” “The Toxic-Free Medical Devices Act was fi led because patients should never have to worry that the tools meant to heal them are exposing them to a cancer-linked chemical, especially when safe alternatives already exist in use right here in Massachusetts,” said Senator Joan B. Lovely, lead Senate sponsor of the legislation. “Seeing this advance through the Legislature brings Massachusetts to the brink of leading the nation on exemplary medical care. I want to thank Senate President Spilka and Senate Ways and Means Chair Rodrigues for their leadership, and our colleague Representative James O’Day for his partnership as House sponsor.” “Massachusetts has always been a leader in health care innovation, and we here in the Commonwealth have a responsibility to continue advancing policies that make care safer for the people who need it most,” said Representative James J. O’Day (DWest Boylston), Fourth Division Chair and lead House sponsor of the legislation. “This legislation reduces unnecessary exposure to DEHP in medical devices while giving hospitals and providers the flexibility needed for a responsible transition to safer alternatives. I’m grateful to Senator Lovely for her partnership, Speaker Mariano for his leadership, and all the advocates, stakeholders, and colleagues who worked together to bring this important public health measure across the fi nish line.” Having been passed by the Legislature, the bill has been sent to Governor Maura Healey’s desk for her signature. For Advertising with Results, call The Adv call The Advocatocate Newspapers Newspapers at 781-286-8500 or Info@ advocatenews. net
3 Publizr Home